Autres langues Nocturne Acquisition Corporation

Actions

MBTC

KYG6580S1140

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 03/04/2024			Varia. 5j.	Varia. 1 janv.
11,66 ^USD	-0,49%		-.--%	+0,08%

31/03	Cognos Therapeutics Inc. a annulé l'acquisition de Nocturne Acquisition Corporation (NasdaqCM:MBTC) auprès d'un groupe d'actionnaires dans le cadre d'une opération de fusion inversée.	CI
07/02	Nocturne Acquisition Corporation annonce des changements de direction	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite Index	03/04
Cognos Therapeutics Inc. cancelled the acquisition of Nocturne Acquisition Corporation from a group of shareholders in a reverse merger transaction.	31/03
Nocturne Acquisition Corporation Announces Management Changes	07/02
Sector Update: Financial Stocks Ease Late Afternoon	05/02
Sector Update: Financial	05/02
Nocturne Acquisition Shares Jump as Stockholders' Vote on Merger With Cognos Therapeutics Postponed Further	05/02
Nocturne Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing	21/09/23
Nocturne Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23
Nocturne Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23/06/23
Nocturne Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	26/05/23
Nocturne Acquisition Corporation Auditor Raises 'Going Concern' Doubt	26/05/23
NOCTURNE ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	02/05/23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/04/23
NOCTURNE ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	06/04/23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure (form 8-K)	03/04/23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09/01/23
NOCTURNE ACQUISITION CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04/01/23
Nocturne Acquisition in Deal to Merge With Cognos Therapeutics	03/01/23
Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation from Nocturne Sponsor, LLC, Polar Asset Management Partners Inc., Periscope Capital Inc, Sea Otter Advisors LLC and others for approximately $120 million in a reverse merger transaction.	03/01/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nocturne Acquisition Corporation

Actions

MBTC

KYG6580S1140

Autres langues

Filtres